Streetbeat News

Products Services

GSK

NNVC

PFE

NanoViricides Inc (NNVC) shares are trading higher after the company reported positive preclinical data for its antiviral clinical drug candidate NV-387 for Respiratory Syncytial Virus (RSV). NV-387 is also the active ingredient of NV-CoV-2, the company's drug for COVID. The company plans to advance NV-387 into Phase 2 studies against RSV once the current Phase 1 studies of NV-CoV-2 are completed. GSK plc's (GSK) Arexvy and Pfizer Inc's (PFE) Abrysvo have recently been approved for RSV prophylaxis.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:51 pm

TNDM

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has received FDA clearance for the Tandem Mobi insulin pump for people with diabetes age 6 and up. The Tandem Mobi is fully controllable from a mobile app and is the world's smallest durable automated insulin delivery system. A limited release of Tandem Mobi is expected to start in late 2023 with full commercial availability planned in early 2024.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 4:50 pm

BA

Boeing Company (NYSE:BA) announced its Q2 2023 program deliveries, which included 136 commercial airplane deliveries. The detailed financial results for the quarter will be provided on July 26. The deliveries included 103 units of 737, 8 units of 767, 5 units of 777, and 20 units of 787. The company also delivered various defense, space, and security programs.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 4:47 pm

KSCP

Knightscope's shares are trading higher following the announcement that Georgia State University has chosen Knightscope Authorized Partner TS&L to supply and install K1 Blue Light Towers and Call Boxes at its downtown Atlanta campus.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:41 pm

LYV

Taylor Swift's concert tour is facing ticketing issues in France due to overwhelming demand, causing Ticketmaster, a subsidiary of Live Nation Entertainment (NYSE:LYV), to temporarily suspend sales. Technical glitches on Ticketmaster's website left fans unable to log in, with a queue of over 700,000 fans trying to secure tickets. This follows similar issues with U.S. shows in November 2022. Live Nation shares are currently trading at $93.14, up 35% year-to-date in 2023.

Portfolio Pulse from Chris Katje

July 11, 2023 | 4:28 pm

DERM

Journey Medical Corporation's shares have dropped following the release of topline results from its two Phase 3 trials of DFD-29 for papulopustular rosacea in adults.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:20 pm

NNVC

NanoViricides reported effectiveness of its antiviral drug candidate in an animal model with respiratory syncytial virus infection, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:18 pm

AMD

Shares of Advanced Micro Devices (AMD) are trading lower following reports of delays in the release of its MI300 product.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:16 pm

ELOX

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) shares surged after Oppenheimer raised its price target from $50 to $55. The company also announced the publication of preclinical data demonstrating activity for ZKN-157 against subtypes of colorectal cancer. ELOX shares have been halted for volatility multiple times and are up over 115% on heavy trading volume.

Portfolio Pulse from Erica Kollmann

July 11, 2023 | 4:12 pm

QCOM

The Nothing Phone (2) has been launched in the US, featuring LED lights, a clean Android experience, and flagship-tier hardware including a Qualcomm Snapdragon 8 Plus Gen 1 chipset. The phone is priced starting at $599, with pre-orders live and open sales beginning on July 17.

Portfolio Pulse from Rounak Jain

July 11, 2023 | 4:10 pm